Skip to main content
OpenTrials

Clinical trial condition

Attention-Deficit/Hyperactivity Disorder

Explore clinical trials studying Attention-Deficit/Hyperactivity Disorder. Study availability and eligibility vary by location and protocol.

63 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Attention-Deficit/Hyperactivity Disorder trial results

Active, not recruiting

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

NCT02736656

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Alliance for Wellness dba Alliance for Research Long Beach, California, United States
  • MCB Clinical Research Centers, LLC Colorado Springs, Colorado, United States
  • Meridien Research at Florida Clinical Research Center Bradenton, Florida, United States
View all 16 locations
View Trial Details
Completed

Effects of LDX on Functioning of College Students With ADHD

NCT01342445

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Department of Education and Human Services, Lehigh University Bethlehem, Pennsylvania, United States
  • Department of Psychology, University of Rhode Island Kingston, Rhode Island, United States
View Trial Details
Completed

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

NCT04143217

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • South California Research LLC Beverly Hills, California, United States
  • Collaborative Neuroscience Network Garden Grove, California, United States
  • Pharmacology Research Institute Los Alamitos, California, United States
  • Pharmacology Research Institute Newport Beach, California, United States
View all 38 locations
View Trial Details

Related conditions